Cargando…

Determinants of informal care time, distress, depression, and quality of life in care partners along the trajectory of Alzheimer's disease

INTRODUCTION: We evaluated determinants associated with care partner outcomes along the Alzheimer's disease (AD) stages. METHODS: We included n = 270 care partners of amyloid‐positive patients in the pre‐dementia and dementia stages of AD. Using linear regression analysis, we examined determina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mank, Arenda, van Maurik, Ingrid S., Rijnhart, Judith J. M., Rhodius‐Meester, Hanneke F. M., Visser, Leonie N. C., Lemstra, Afina W., Sikkes, Sietske A. M., Teunissen, Charlotte E., van Giessen, Elsmarieke M., Berkhof, Johannes, van der Flier, Wiesje M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126754/ https://www.ncbi.nlm.nih.gov/pubmed/37114014 http://dx.doi.org/10.1002/dad2.12418

Ejemplares similares

Life satisfaction across the entire trajectory of Alzheimer's disease: A mediation analysis
por: Mank, Arenda, et al.
Publicado: (2022)

A longitudinal study on quality of life along the spectrum of Alzheimer’s disease
por: Mank, Arenda, et al.
Publicado: (2022)

Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease
por: Mank, Arenda, et al.
Publicado: (2022)

Biomarker testing in MCI patients—deciding who to test
por: van Maurik, Ingrid S., et al.
Publicado: (2021)

Disease-related determinants are associated with mortality in dementia due to Alzheimer’s disease
por: Rhodius-Meester, Hanneke F. M., et al.
Publicado: (2018)

Development and design of a diagnostic report to support communication in dementia: Co‐creation with patients and care partners
por: van Gils, Aniek M., et al.
Publicado: (2022)

Identifying relevant outcomes in the progression of Alzheimer's disease; what do patients and care partners want to know about prognosis?
por: Mank, Arenda, et al.
Publicado: (2021)

Assessing the Views of Professionals, Patients, and Care Partners Concerning the Use of Computer Tools in Memory Clinics: International Survey Study
por: van Gils, Aniek M, et al.
Publicado: (2021)

Survival in memory clinic cohort is short, even in young-onset dementia
por: Rhodius-Meester, Hanneke Frederica Maria, et al.
Publicado: (2019)

Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy Bodies
por: van Gils, Aniek M., et al.
Publicado: (2022)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

Orthostatic Hypotension: An Important Risk Factor for Clinical Progression to Mild Cognitive Impairment or Dementia. The Amsterdam Dementia Cohort
por: Kleipool, Emma E.F., et al.
Publicado: (2019)

Psychosocial Effects of Corona Measures on Patients With Dementia, Mild Cognitive Impairment and Subjective Cognitive Decline
por: van Maurik, Ingrid S., et al.
Publicado: (2020)

Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands
por: Ottenhoff, Lois, et al.
Publicado: (2023)

Evaluation of the Digital Alzheimer Center: Testing Usability and Usefulness of an Online Portal for Patients with Dementia and Their Carers
por: Hattink, Bart, et al.
Publicado: (2016)

Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021)

Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression
por: van de Beek, Marleen, et al.
Publicado: (2020)

Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy
por: Rhodius-Meester, Hanneke F. M., et al.
Publicado: (2020)

Differential diagnosis of neurodegenerative diseases using structural MRI data
por: Koikkalainen, Juha, et al.
Publicado: (2016)

MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis
por: Rhodius-Meester, Hanneke F. M., et al.
Publicado: (2017)

Clinical Phenotypes of Behavioral Variant Frontotemporal Dementia by Age at Onset
por: Fieldhouse, Jay L.P., et al.
Publicado: (2021)

Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals
por: Hendriksen, Heleen M. A., et al.
Publicado: (2023)

Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease)
por: Dreves, Maria A. E., et al.
Publicado: (2023)

Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment
por: van de Beek, Marleen, et al.
Publicado: (2022)

Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics
por: Thorlacius-Ussing, Gorm, et al.
Publicado: (2021)

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023)

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier
por: Tolonen, Antti, et al.
Publicado: (2018)

Evaluating combinations of diagnostic tests to discriminate different dementia types
por: Bruun, Marie, et al.
Publicado: (2018)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study
por: Hok‐A‐Hin, Yanaika S., et al.
Publicado: (2023)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
por: Dubbelman, Mark A., et al.
Publicado: (2020)

Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
por: Coomans, Emma M., et al.
Publicado: (2023)

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies
por: Chatterjee, Madhurima, et al.
Publicado: (2020)

cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
por: Rhodius‐Meester, Hanneke F.M., et al.
Publicado: (2020)

Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report
por: Verrijp, Merike, et al.
Publicado: (2022)

Web-Based Multidomain Lifestyle Programs for Brain Health: Comprehensive Overview and Meta-Analysis
por: Wesselman, Linda MP, et al.
Publicado: (2019)

ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics
por: Fruijtier, Agnetha D., et al.
Publicado: (2019)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

Computer-assisted prediction of clinical progression in the earliest stages of AD
por: Rhodius-Meester, Hanneke F.M., et al.
Publicado: (2018)

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

Dutch Brain Research Registry for study participant recruitment: Design and first results
por: Zwan, Marissa D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ivltacf7dc688fbi2cem7i3t77